drugset / Trial / NCT06654700
Phase III Clinical Trial of Lot-to-lot Consistency of Recombinant Herpes Zoster Vaccine (CHO Cell).
RandomizedParallel-groupTriple-blindPrevention
Summary
To evaluate the lot-to lot consistency of three batches of recombinant herpes zoster vaccine (CHO cell) produced on a commercial scale in subjects aged 40 years and older after receiving 2 doses on a 0, 2 month schedule.
Timeline
- Start
- 2024-12-09
- Primary completion
- 2025-05-01
- Completion
- 2025-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Recombinant Zoster Vaccine (CHO Cell) | Vaccine | 50 ug | Intramuscular |
| Subject | Recombinant Zoster Vaccine (CHO Cell) | Vaccine | 0.5 ml | Intramuscular |